Skip to main content

See our Pipelines

With assistance from the Office of Cooperative Research, over 50 companies based on faculty inventions have spun out of Yale and have collectively raised $5 billion in equity capital in the last 15 years. Many of these startups are dedicated to advancing new therapies and medical devices to market by licensing cutting-edge Yale research to one of our many corporate partners.

There are 51 products in Yale's Pharmaceutical Pipeline.

Pharmaceutical Pipeline 11.5.2019.png
dd_pipeline.png